Table 1.
Patient characteristics (cohort II and CD*)
| Characteristic | Value |
|---|---|
| Patients with GPA, n | 22 |
| Men/women, n | 14/8 |
| GPA in remission, n (%) | 12/22 (55 %) |
| Age in years, median (range) | 55.5 (35–79) |
| Duration of remission in years (of inactive GPA), mean (range) | 4.4 (1–20) |
| GPA non remission (active), n (%) | 10/22 (45 %) |
| Age in years, median (range) | 51.5 (33–64) |
| BVAS, mean (range) | 4.5 (0–19) |
| Localized GPA (upper airways and ENT organs only), n (%) | 4/22 (18 %) |
| Generalized GPA, n (%) | 18/22 (82 %) |
| ANCA | |
| Positive | 17/22 (77 %) |
| Negative | 3/22 (14 %) |
| Not determinable | 2/28 (9 %) |
| Patients with CD, n | 12 |
| Men/women, n | 3/9 |
GPA granulomatosis with polyangiitis, BVAS Birmingham vasculitis activity score, ENT ear, nose and throat, ANCA antineutrophil cytoplasmic antibody, CD* inactive systemic inflammatory control diseases other than GPA comprising systemic lupus erythematosus (n = 4), panarteriitis nodosa (n = 1), overlap connective tissue disease (n = 1), chronic inflammatory bowel disease (n = 1), CREST syndrome (n = 1), primary Sjögren’s syndrome (n = 1), polymyalgia rheumatica (n = 1) and giant cell arteriitis (n = 2)